Robocath will launch its new robotic platform, R-One+, for coronary angioplasties at the EuroPCR 2023 conference in Paris. The Rouen, France-based robotics company says the technology will not only reduce radiation-induced injuries but also make procedures safer and easier.

A coronary angioplasty is used to widen blocked or narrowed coronary arteries. Coronary heart disease is a common condition that results from this. The Centers for Disease Control and Prevention estimate that approximately 20 million adults have coronary heart disease. Although coronary angioplasties are relatively safe, the procedures still carry risks.

The R-One+ has two components: a command unit and the robotic unit itself. The platform allows the cardiologist to control devices from the control command unit which can be positioned in the catheterisation laboratory (cath lab) or in the control room. As Dr. Mohammed Nejjari, interventional cardiologist at the Centre Cardiologique du Nord (CCN) in Saint-Denis, France, explains, the system protects the cardiologist from radiation-induced injuries.

“I was able to perform several robotic angioplasties from the control room, where I was completely shielded from X-rays and could dispense with my lead apron,” Dr Nejjari said. “I also benefited from the excellent visibility on the radioscopy and hemodynamic monitoring screens.”

The robotic unit consists of the robot and its articulated support arm, with millimeter precision. Professor Michael Haude, interventional cardiologist at the Lukaskrankenhaus Hospital in Neuss, Germany, believes that robotics can play a significant part in advancing cardiovascular medicine.

“I firmly believe that robotics has a major role to play in the transformation of interventional cardiology and the use of this technology will mark a new chapter in the history of our field,” said Haude.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData

The robotics industry is growing at a CAGR of 29% and will be worth $568bn by 2030, according to GlobalData. Whilst exoskeletons and industrial robots lead the charge, medical robots occupy the lower end of CAGR. However, within the healthcare industry itself, robotics is one of the fastest areas of growth – the robotic medical devices market will be worth $14.5bn by 2030.